Radiotherapy for Lung Cancer: What Is Our Current Role and Where Are Our Future Opportunities - ARC2019

This course reviews the state-of-the-art treatment approaches for lung cancer. The presentation will include best-practices for lung cancer: (1) role of lung cancer screening, (2) staging, (3) appropriate clinical work-up, (4) incorporating multi-modality imaging, (5) advanced radiation treatment planning (IMRT, SABR, hypofractionated), (6) using modern image-guidance and advanced delivery techniques (non-coplanar therapy, proton therapy, MR-guided radiotherapy). The course will also review the relevant evidence-based literature on the incorporation of radiotherapy for stages I-IV for Non-small-cell lung cancer (NSCLC), oligometastatic NSCLC, as well as limited and extensive stage SCLC.

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, physicists, nurses, radiation therapists, and radiation dosimetrists.

Learning Objectives

  • Explore the role of lung cancer screening, best-practices using low-dose CT for lung cancer screening, who are the optimal candidates to offer lung cancer screening, and the best treatment options for screen-detected early stage lung cancer
  • Identify who are inoperable early stage NSCLC lung cancer patients, and use best-practices to deliver the highest quality SABR for these patients
  • Match optimal chemoradiotherapy to patients with unresectable stage III NSCLC in conjunction with consolidative durvalumab.
  • Identify optimal candidates with oligometastatic or oligoprogressive NSCLC that will most likely derive a clinical benefit with aggressive local consolidative therapies (e.g. surgery or SABR).
     
Course summary
Available credit: 
  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
05/24/2019
Course expires: 
05/23/2022
Cost:
$105.00
Rating: 
0

Percy Lee, MD is employed by the University of California, receives compensation/remuneration/funding from AstraZeneca, Inc., Varian Inc., Viewray and holds a leadership position at AAPM HYTEC Thoracic TCP Sub-committee.

The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.50 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Accreditation Period

Course opens: 
05/24/2019
Course expires: 
05/23/2022

Price

Cost:
$105.00
Please login or register to take this course.

Course Fees:

ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $105
  • Member: $55

Policies: 

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.